Search results for: 'line companies'

Frost & Sullivan has recently completed a comprehensive analysis on the current and future strategic imperatives of game-changing Asia-Pacific (APAC) pharmaceutical companies. The analysis primarily focuses on the changing trends in the pharmaceutical industry with respect to drug research and development, manufacturing, supply chain, and marketing...

This research highlights the analysis of two core benchmarking categories, namely macro indicators and micro indicators, for successful IFM companies in Asia Pacific. The categories are meant to illustrate nine leading IFM companies performance in Asia Pacific . The benchmarking criteria are built around two categories with fifteen individual indi...

This research service provides a detailed overview and analysis of ten specialty pharmaceutical companies. They have been chosen by taking into account certain critical indicators such as revenues, research and development (R&D) expenditure, current drug pipeline, earnings per share, stock price appreciation, return on investment, and net income.

Spacefaring and lunar exploration are among the biggest endeavors of civilization. In this report, Frost & Sullivan explores growth opportunities that can unlock space as the next frontier. The study includes an overview of the global space industry, top emerging megatrends, competitive landscape, innovation and technology landscape, opportuniti...

Globally, start-ups are making waves in the water industry, especially in the US and Europe. In Asia-Pacific, competition among the water start-ups’ is intense too, especially in more developed economies, namely Singapore and Australia. In Southeast Asia, Singapore is a thriving center of innovation excellence in water. Therefore, the growing prese...

The research service primarily focuses on the changing trends in the pharmaceutical industry with respect to drug research and development, manufacturing, supply chain, and marketing. The study provides key insights into the transforming pharmaceutical value chain, with the adoption of technology and shift towards digitalization of key processes ac...

The global pharmaceutical industry is continuously evolving. with the rising need for novel therapies in the ever-changing disease landscape. As a result of rising prevalence of chronic infectious diseases as well as continuously growing number of cancer cases, market needs are shifting from traditional, small molecules to novel, large-molecule the...

Despite the term patient centricity gaining currency in the industry, there is a degree of variability in a companies’ approach and strategic priorities. Frost & Sullivan sees digitization playing a critical role in transforming the clinical trial model from traditional, high-cost, and difficult-to-access centralized settings to more patient-centri...

This study analyzes the global crop protection market and profiles the 20 leading companies that are active in this space; it also offers an outlook of the key trends that drive the market. By geography, the study is classified into 4 regions, namely, North America, Europe, Asia-Pacific (APAC), and Rest-of-World (RoW). Product scope includes crop p...